Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesDigital X-RaySocioeconomic conditions amplify pollution-related bone lossThe findings underscore how environmental and social conditions work together to influence long-term bone health.Practice ManagementMedicare Advantage cost-sharing varies for advanced imaging servicesWomens ImagingSNAP participation boosts cancer screening among food-insecure adultsMolecular ImagingPET/CT guides treatment in men with recurrent prostate cancerAIMost patients want to know if AI being used for imaging reports
